Search Results | Blood | American Society of Hematology

1-20 of 116

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Venetoclax, Cladribine Plus Low-Dose Cytarabine Achieved High Remission in Patients with Relapse/Refractory Acute Leukemia: Preliminary Results of a Phase II Study

Yanyan Li, Haixia Zhou, Chaoling Wan, Mingzhu Xu, Chongsheng Qian, Tongtong Zhang, Haiping Dai, AiNing Sun, Depei Wu, Shengli Xue

Blood (2022) 140 (Supplement 1): 3212–3213.

DOI: https://doi.org/10.1182/blood-2022-168054

Published: 2022

Journal Articles

Integrative Genomic and Transcriptomic Profiling Reveals Distinct Molecular Subsets in Adult Mixed Phenotype Acute Leukemia

Qian Wang, Haiping Dai, Wenzhi CAI, Qinrong Wang, Zhu Mingqing, Lingzhi Yan, Yan Yu, Hongjie Shen, Yang Xu, Ying Wang, Miao Miao, Shengli Xue, Yue Han, Xiaowen Tang, Huiying Qiu, Aining Sun, Jinyan Huang, Depei Wu, Suning Chen

Blood (2022) 140 (Supplement 1): 9198–9200.

DOI: https://doi.org/10.1182/blood-2022-156862

Published: 2022

Journal Articles

Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial

Jundan Xie, Xiaofei Yang, Xiebing Bao, Hongjie Shen, Jiannong Cen, Li Yao, Xiaohui Hu, Qian Wu, Jingren Zhang, Xuefeng He, Xiaowen Tang, AiNing Sun, Hongchun Qiu, Shengli Xue, Ying Wang, Jianhong Fu, Huiying Qiu, Depei Wu, Suning Chen

Blood (2022) 140 (Supplement 1): 1439–1440.

DOI: https://doi.org/10.1182/blood-2022-166384

Published: 2022

Journal Articles

Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial

Suning Chen, Jundan Xie, Xiaofei Yang, Hongjie Shen, Jiannong Cen, Li Yao, Xiaohui Hu, Qian Wu, Jingren Zhang, Hongchun Qiu, Xiaowen Tang, Aining Sun, Shengli Xue, Ying Wang, Huiying Qiu, Depei Wu

Blood (2021) 138 (Supplement 1): 35.

DOI: https://doi.org/10.1182/blood-2021-153288

Published: 2021

Journal Articles

Tandem CD19/CD22 Dual Targets CAR-T Cells Therapy Obtains Superior CR Rate Than Single CD19 CAR-T Cells Infusion As Well As Sequential CD19 and CD22 CAR-T Cells Infusion for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients

Blood (2021) 138 (Supplement 1): 1755.

DOI: https://doi.org/10.1182/blood-2021-152927

Published: 2021

Journal Articles

Maintenance Therapy with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation to Prevent Relapse of High Risk Acute Myeloid Leukemia

Yunju Ma, Changju Qu, PhD, Haiping Dai, Jia Yin, Zheng Li, Jia Chen, Huiying Qiu, Aining Sun, PhD, Miao Miao, Chengcheng Fu, Zhengming Jin, MD, Xiaming Zhu, Depei Wu, MD PhD, Xiaowen Tang

Blood (2019) 134 (Supplement_1): 3306.

DOI: https://doi.org/10.1182/blood-2019-124033

Published: 2019

Journal Articles

Outcomes of Haploidentical Haematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Haemoglobinuria

Limin Liu, MD PhD, Huifen Zhou, Miao Miao, Depei Wu, MD PhD, Xiaowen Tang, Huiying Qiu, PhD, Yue Han, MD, Zhengming Jin, MD, Suning Chen, Aining Sun, PhD, Qingyuan Wang, MD

Blood (2019) 134 (Supplement_1): 5730.

DOI: https://doi.org/10.1182/blood-2019-131808

Published: 2019

Journal Articles

Outcomes of Unrelated Cord Blood Transplantation for 18 Patients with Severe Aplastic Anemia

Limin Liu, Miao Miao, Huiying Qiu, PhD, XiaoWen Tang, MD, Yue Han, MD, Chengcheng Fu, Zhengming Jin, Aining Sun, PhD, Depei Wu, MD

Blood (2017) 130 (Supplement 1): 5554.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.5554.5554

Published: 2017

Journal Articles

Outcomes of Combination of HLA-Haploidentical Hematopoietic SCT with an Unrelated Cord Blood Unit for 127 Patients with Acquired Severe Aplastic Anemia

Miao Miao, Limin Liu, Huiying Qiu, PhD, XiaoWen Tang, MD, Yue Han, MD, Chengcheng Fu, Zhengming Jin, Aining Sun, PhD, Depei Wu, MD

Blood (2017) 130 (Supplement 1): 4574.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.4574.4574

Published: 2017

Journal Articles

Low-Dose Decitabine Combined with Modified Bucy Is More Effective Conditioning Regimen for High-Risk Patients with Acute Myeloid Leukaemia/Myelodysplastic Syndrome

Xiaowen Tang, MD, Jing Cao, Xiaojing Shi, Ling Ge, Aining Sun, PhD, Xiaming Zhu, Huiying Qiu, Zhengming Jin, Miao Miao, Chengcheng Fu, Xiao Ma, Feng Chen, Shengli Xue, Yue Han, MD, Mengxing Xue, Xinliang Mao, PhD, Depei Wu, MD PhD

Blood (2016) 128 (22): 5750.

DOI: https://doi.org/10.1182/blood.V128.22.5750.5750

Published: 2016

Journal Articles

Mir-130a Is Aberrantly Overexpressed in Adult Acute Myeloid Leukemia with t(8;21) and Its Suppression Induces AML Cell Death

Haiping Dai, Chao Ding, Suning Chen, Roderick A. F. MacLeod, Stefan Ehrentraut, Hans G. Drexler, Stefan Nagel, PhD, Depei Wu, MD PhD, Aining Sun, PhD

Blood (2016) 128 (22): 5096.

DOI: https://doi.org/10.1182/blood.V128.22.5096.5096

Published: 2016

Journal Articles

Study on the Pathogenesis and Clinical Significance of FLT3 and C-KIT Mutations in Core-Binding Factor AML

Aining Sun, PhD, Ji Shimeng, Suning Chen, Tongtong Zhang, Depei Wu, MD PhD

Blood (2016) 128 (22): 5236.

DOI: https://doi.org/10.1182/blood.V128.22.5236.5236

Published: 2016

Journal Articles

Decitabine Combined with Haag Regimen Is an Effective Salvage Treatment for Advanced Acute Myeloid Leukemia

XiaoWen Tang, MD, Wei Cui, Zhengming Jin, Xiaming Zhu, Aining Sun, PhD, Huiying Qiu, Miao Miao, Jing Cao, Dandan Guo, Depei Wu, MD PhD

Blood (2016) 128 (22): 5205.

DOI: https://doi.org/10.1182/blood.V128.22.5205.5205

Published: 2016

Journal Articles

Haploidentical Stem Cell Transplantation after Myeloabaltive Conditioning Is a Valid and Safe Option for Young Patients with Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma: A Study Compared with HLA-Matched Transplant

Haiwen Huang, Xiaofang Xiao, Jia Chen, Zhengming Jin, Xiaowen Tang, MD, Huiying Qiu, Chengcheng Fu, Yue Han, MD, Miao Miao, Huirong Chang, Aining Sun, PhD, Depei Wu, MD PhD

Blood (2016) 128 (22): 5849.

DOI: https://doi.org/10.1182/blood.V128.22.5849.5849

Published: 2016

Journal Articles

Impact of Disease Status on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Refractory and Relapsed Acute Lymphoblastic Leukemia

Jing Cao, Xiaoming Zhu, Aining Sun, PhD, Huiying Qiu, Zhengming Jin, Miao Miao, Depei Wu, MDPhD, XiaoWen Tang, MD

Blood (2016) 128 (22): 5862.

DOI: https://doi.org/10.1182/blood.V128.22.5862.5862

Published: 2016

Journal Articles

Increased Mir-155 Expression Is Associated with FLT3-ITD Mutation and Poor Therapy Response in Chinese AML and Allo-HSCT Could Improve Survival of These Patients

Xiaofei Yang, Aining Sun, PhD, Xingxing Hu, Wenjuan Ma, Depei Wu, MD PhD

Blood (2016) 128 (22): 5841.

DOI: https://doi.org/10.1182/blood.V128.22.5841.5841

Published: 2016

Journal Articles

A Comparison Study Between Allogeneic and Autologous Hematopoietic Stem Cell Transplant for High-Risk Peripheral T-Cell Lymphomas (PTCL)

Haiwen Huang, Qiangli Wang, Zhengming Jin, XiaoWen Tang, MD, Huiying Qiu, Chengcheng Fu, Yue Han, MD, Miao Miao, Huirong Chang, Aining Sun, PhD, Depei Wu, MD PhD

Blood (2016) 128 (22): 5845.

DOI: https://doi.org/10.1182/blood.V128.22.5845.5845

Published: 2016

Journal Articles

Pre-Emptive Therapy with IFN-α-2b for Acute Leukemia Patients with High Risk of Relapsing Tendency Post Allo-HSCT

XiaoWen Tang, MD, Xiaoji Lin, Aijing Wang, Feng Chen, Xiao Ma, Aining Sun, PhD, Xiaming Zhu, Huiying Qiu, Zhengming Jin, Shengli Xue, Depei Wu, MD PhD

Blood (2016) 128 (22): 2250.

DOI: https://doi.org/10.1182/blood.V128.22.2250.2250

Published: 2016

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Severe Aplastic Anemia

Miao Miao, Xiang Zhang, Ting Xu, Song Jin, Hong Wang, Xiaofei Yang, Zhijuan Pan, Jun He, Aining Sun, PhD, Wu Depei, MD

Blood (2015) 126 (23): 3227.

DOI: https://doi.org/10.1182/blood.V126.23.3227.3227

Published: 2015

Journal Articles

Alterations of Plasma Complement C3b, C5b and VWF, ADAMTS13 in Patients with Graft-Versus-Host Disease and Thrombotic Microangiopathy after Hematopoietic Stem-Cell Transplantation

Yue Han, MD, Jie Wang, Jia Chen, Jiaqian Qi, Jian Su, Zhenni Ma, Yaqiong Tang, Wei Han, Aining Sun, PhD, Zhaoyue Wang, Changgeng Ruan, MD, PhD, Wu Depei, MD

Blood (2015) 126 (23): 3143.

DOI: https://doi.org/10.1182/blood.V126.23.3143.3143

Published: 2015

2 3 4 5

NARROW

Venetoclax, Cladribine Plus Low-Dose Cytarabine Achieved High Remission in Patients with Relapse/Refractory Acute Leukemia: Preliminary Results of a Phase II Study

Integrative Genomic and Transcriptomic Profiling Reveals Distinct Molecular Subsets in Adult Mixed Phenotype Acute Leukemia

Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial

Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial

Tandem CD19/CD22 Dual Targets CAR-T Cells Therapy Obtains Superior CR Rate Than Single CD19 CAR-T Cells Infusion As Well As Sequential CD19 and CD22 CAR-T Cells Infusion for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients

Maintenance Therapy with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation to Prevent Relapse of High Risk Acute Myeloid Leukemia

Outcomes of Haploidentical Haematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Haemoglobinuria

Outcomes of Unrelated Cord Blood Transplantation for 18 Patients with Severe Aplastic Anemia

Outcomes of Combination of HLA-Haploidentical Hematopoietic SCT with an Unrelated Cord Blood Unit for 127 Patients with Acquired Severe Aplastic Anemia

Low-Dose Decitabine Combined with Modified Bucy Is More Effective Conditioning Regimen for High-Risk Patients with Acute Myeloid Leukaemia/Myelodysplastic Syndrome

Mir-130a Is Aberrantly Overexpressed in Adult Acute Myeloid Leukemia with t(8;21) and Its Suppression Induces AML Cell Death

Study on the Pathogenesis and Clinical Significance of FLT3 and C-KIT Mutations in Core-Binding Factor AML

Decitabine Combined with Haag Regimen Is an Effective Salvage Treatment for Advanced Acute Myeloid Leukemia

Haploidentical Stem Cell Transplantation after Myeloabaltive Conditioning Is a Valid and Safe Option for Young Patients with Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma: A Study Compared with HLA-Matched Transplant

Impact of Disease Status on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Refractory and Relapsed Acute Lymphoblastic Leukemia

Increased Mir-155 Expression Is Associated with FLT3-ITD Mutation and Poor Therapy Response in Chinese AML and Allo-HSCT Could Improve Survival of These Patients

A Comparison Study Between Allogeneic and Autologous Hematopoietic Stem Cell Transplant for High-Risk Peripheral T-Cell Lymphomas (PTCL)

Pre-Emptive Therapy with IFN-α-2b for Acute Leukemia Patients with High Risk of Relapsing Tendency Post Allo-HSCT

Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Severe Aplastic Anemia

Alterations of Plasma Complement C3b, C5b and VWF, ADAMTS13 in Patients with Graft-Versus-Host Disease and Thrombotic Microangiopathy after Hematopoietic Stem-Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only